Zobrazeno 1 - 10
of 31
pro vyhledávání: '"M. P. GOWRAV"'
Autor:
M. P. Gowrav, K. G. Siree, T. M. Amulya, M. B. Bharathi, Mohammed Ghazwani, Ali Alamri, Abdulatef Y. Alalkami, T. M. Pramod Kumar, Mohammed Muqtader Ahmed, Mohamed Rahamathulla
Publikováno v:
Polymers, Vol 15, Iss 11, p 2521 (2023)
A novel approach to the treatment of sinusitis is the use of nasal stents. The stent is loaded with a corticosteroid, which prevents complications in the wound-healing process. The design is such that it will prevent the sinus from closing again. The
Externí odkaz:
https://doaj.org/article/c75dc66c16f3491e900d312da67e6078
Publikováno v:
International Journal of Pharmaceutical Investigation; Apr-Jun2024, Vol. 14 Issue 2, p299-305, 7p
Publikováno v:
Journal of International Research in Medical and Pharmaceutical Sciences. :26-34
Brazil, which has the most people of any country in South America, just overtook India to become the country with the second-largest pharmaceutical sector in the entire globe. The National Health Surveillance Agency of Brazil, also known as Agência
Autor:
M. P. Gowrav, B. G. Ramu, K. Divith, S. Sowmya, T. M. Pramod Kumar, T. M. Amulya, K. G. Siree
Publikováno v:
Journal of Pharmaceutical Research International. :207-218
Three-dimensional (3D) printing is a unique technique that allows for a high degree of customisation in pharmacy, dentistry and in designing of medical devices. 3D printing satiates the increasing exigency for consumer personalisation in these fields
Publikováno v:
Journal of Pharmaceutical Research International. :244-261
Exosomes are also known as extracellular vesicles (EVs) which is bounded by a membrane mostly seen in eukaryotic cells secreted within the endosomal compartment along with some of the selected composition of RNA, proteins, lipids and DNA. They are ca
Autor:
M. P. Gowrav, Gorthi Nihar, K. Divith, M. B. Bharathi, T. M. Pramod Kumar, K. G. Siree, T. M. Amulya
Publikováno v:
Journal of Pharmaceutical Research International. :52-64
The scope and applications of biomaterials have spread out throughout a broad spectrum. Particularly in pharmacy, biomaterials are an attractive choice because they can be modified to decrease toxicity, increase the targeting ability among many other
Autor:
Akhilesh Akki, M. P. Gowrav, Vishakharaju Motupalli, M. P. Venkatesh, V. Balamuralidhara, S. Narmada
Publikováno v:
Journal of Pharmaceutical Research International. :276-288
Pharmacovigilance is a tool proposed during the post-marketing process of the pharmaceutical product lifecycle to monitor drug safety in everyday life and to identify adverse drug reactions. The identification of adverse reactions, however, is a sign
Publikováno v:
Journal of Pharmaceutical Research International. :438-450
Adaptation towards digitalization in pharmaceuticals leads to the utilization and development of Artificial Intelligence (AI). Significantly it is reducing human workload with the help of an algorithm. Already AI is acting as a key in clinical trial,
Autor:
R. Gajbhiye Kavita, Mueed Zeba, Gilardi Daniela, Kumar Somareddy Hemanth, Karami Dolisgan Kimia, H.V. Gangadharappa, Kumar Rai Pankaj, Baradaran Behzad, Dubey Akhilesh, Nguyen Tien-Dat, Quyen-Do, Nguyen Canh-Hung, Pawar Abhishek, Bansal Parveen, Tung Nguyen-Thach, Siddique Seemab, M. P. Gowrav, Safaee Sahar, Furfaro Federica, Zacharopoulou Eirini, Alfarone Ludovico, Fiorino Gionata, Allocca Mariangela, Roda Giulia, G. Shriram Ravi, Nguyen Thanh-Binh, Korake Swati, Bui Quang-Dong, Kumar Poddar Nitesh, A. El-Zahaby Sally, Hatwal Deepa, K. Dwivedi Deepak, Mohammadi Ali, Gupta Vikas, Danese Silvio, Shanbhogue H. Maithri, Samir Safia, Goyal Suresh, Loy Laura, Sharma Priyanka, Zilli Alessandra, Maithani Mukesh, Do Thi-Phuong-Chi, Nguyen Duc-Cuong, Anbari Khatereh, Correale Carmen, Fardi Masoumeh, Argollo Marjorie, Thirumaleshwar Shailesh
Publikováno v:
Current Chemical Biology. 15:109-125
The advancements in cancer treatment have no significant effect on ovarian cancer [OC]. The lethality of the OC remains on the top list of gynecological cancers. The long term survival rate of the OC patients with the advanced stage is less than 30%.
Publikováno v:
RESEARCH JOURNAL OF PHARMACY AND TECHNOLOGY. 14:1177-1182